NKGen Biotech, Inc. Warrants (NKGNW)

USD 0.05

(-5.46%)

Market Cap (In USD)

1.77 Million

Revenue (In USD)

-

Net Income (In USD)

-82.95 Million

Avg. Volume

-

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.0398-0.0666
PE
-
EPS
-
Beta Value
0.524
ISIN
US65488A1198
CUSIP
-
CIK
1845459
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Paul Y. Song M.D.
Employee Count
-
Website
https://www.grafacq.com
Ipo Date
Details
Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. Graf Acquisition Corp. IV was incorporated in 2021 and is based in The Woodlands, Texas.